---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015938"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T08:14:26.529758+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ZyVersa Therapeutics executes 1-for-10 reverse stock split effective April 25, 2024

## Summary
- Reverse split ratio 1-for-10; approved by stockholders at special meeting on April 17, 2024.
- Effective at 4:01 p.m. ET on April 25; split-adjusted trading begins April 26 on Nasdaq.
- Par value unchanged; new CUSIP number is 98987D 300.
- Common stock continues trading under symbol ZVSA on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-24-015938
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/0001493152-24-015938-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015938
- JSON: https://secwatch.observer/filing/0001493152-24-015938.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015938.txt

## Key facts
- Governance Changes
  ZyVersa Therapeutics, Inc.: Filed a certificate of amendment to effect a 1-for-10 reverse stock split of common stock (effective 2024-04-25).
  - Change: charter amendment
  - Effective: 2024-04-25
  source text: On April 25, 2024, ZyVersa Therapeutics, Inc. (the "Company") filed a certificate of amendment to the Company’s Second Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware relating to a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock (“Common Stock”). The Reverse Stock Split became effective on April 25, 2024 at 4:01 p.m., and the Common Stock is expected to begin trading on The Nasdaq Capital Market on a Reverse Stock Split-adjusted basis on April 26, 2024 at market open.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/0001493152-24-015938-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.